Biotech startup uses tobacco plants to make vaccines

03/22/2012 | InnovationNewsDaily.com

U.S. biotech startup Inserogen has transformed tobacco plants into biological factories for manufacturing proteins for new vaccines and treatments. Using the SwiftVax tobacco plants, the startup is developing a vaccine for Newcastle disease, and a therapeutic protein for patients with alpha-1 antitrypsin deficiency. "The technology is easy to customize, and can be engineered to produce not only vaccines, but virtually any recombinant protein," Inserogen's Lucas Arzola said.

View Full Article in:

InnovationNewsDaily.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Senior Manager, Clinical Affairs - Advanced Technology
Edwards Lifesciences
Irvine, CA
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park